Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical silymarin gel versus placebo as adjunctive therapy for painful diabetic neuropathy
IRCT20120215009014N501Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetic neuropathy comparing Pregabalin + silymarin gel with Pregabalin + placebo gel (2 arms). Primary endpoints: Pain score and Quality of life score. Started Mar 2024; status: completed.
02
Drugs
silymarin
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on IRCT20120215009014N501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N501.